Board member michael martino to become interim chairman and ceo of ampio pharmaceuticals, mike macaluso to take medical leave

Englewood, colo., nov. 22, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced that mike macaluso is taking a one-year medical leave of absence from his role as chairman and ceo, effective immediately.
AMPE Ratings Summary
AMPE Quant Ranking